Circulating tumor cells (CTCs) are an independent prognostic factor for progression-free survival (PFS) and overall survival (OS) in patients with metastatic breast cancer. Inflammatory breast cancer (IBC) is one of the most aggressive forms of breast cancer. The prognostic value of a CTC count in newly diagnosed IBC has not been established. The aim of this study was to assess the prognostic value of a baseline CTC count in patients with newly diagnosed IBC.
Circulating tumor cells in newly diagnosed inflammatory breast cancer / Mego, Michal; Giordano, Antonio; De Giorgi, Ugo; Masuda, Hiroko; Hsu, Limin; Giuliano, Mario; Fouad, Tamer M; Dawood, Shaheenah; Ueno, Naoto T; Valero, Vicente; Andreopoulou, Eleni; Alvarez, Ricardo H; Woodward, Wendy A; Hortobagyi, Gabriel N; Cristofanilli, Massimo; Reuben, James M.. - In: BREAST CANCER RESEARCH. - ISSN 1465-5411. - 17:1(2015), p. 2. [10.1186/s13058-014-0507-6]
Circulating tumor cells in newly diagnosed inflammatory breast cancer
GIULIANO, MARIO;
2015
Abstract
Circulating tumor cells (CTCs) are an independent prognostic factor for progression-free survival (PFS) and overall survival (OS) in patients with metastatic breast cancer. Inflammatory breast cancer (IBC) is one of the most aggressive forms of breast cancer. The prognostic value of a CTC count in newly diagnosed IBC has not been established. The aim of this study was to assess the prognostic value of a baseline CTC count in patients with newly diagnosed IBC.| File | Dimensione | Formato | |
|---|---|---|---|
|
Mego et Al.BCR2015.pdf
accesso aperto
Tipologia:
Documento in Post-print
Licenza:
Dominio pubblico
Dimensione
1.21 MB
Formato
Adobe PDF
|
1.21 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
